Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatinGianfranco Buccheri, Domenico Ferrigno, Acta Oncologica (Stockholm, Sweden)|April 8, 2004
Familial and personal history of cancer in bronchogenic carcinoma--frequency and clinical implicationsGianfranco Buccheri, Domenico FerrignoAnticancer Research|December 13, 2005
Weekly chemotherapy with cisplatin and paclitaxel in inoperable non-small cell lung cancer: an extended phase II studyDomenico Ferrigno, Gianfranco BuccheriLung Cancer (Amsterdam, Netherlands)|August 11, 2004
Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC)Domenico Ferrigno, Gianfranco Buccheri, Hematology/Oncology Clinics of North America|March 10, 2004
Prognostic factorsGianfranco Buccheri, Domenico FerrignoThe Annals of Thoracic Surgery|March 21, 2003
Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA testGianfranco Buccheri, Domenico FerrignoCancer|June 5, 2003
Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significanceGianfranco Buccheri, Pierfederico Torchio, Domenico FerrignoChest|August 9, 2003
Clinical equivalence of two cytokeratin markers in mon-small cell lung cancer: a study of tissue polypeptide antigen and cytokeratin 19 fragmentsGianfranco Buccheri, Pierfederico Torchio, Domenico FerrignoAnticancer Research|March 2, 2005
Cisplatin and vinorelbine remains a valid option for the front-line chemotherapy treatment of NSCLCGianfranco Buccheri, Domenico Ferrigno, Cristina Giordano, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2003
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC)Domenico Ferrigno, Gianfranco Buccheri, Cristina GiordanoPageof 2